20135 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Stable digestive enzyme compositions
#1502Oral dosage forms for delivery of therapeutic agents
#1503PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER
#1504EXTENDED RELEASE COMPOSITIONS CONTAINING TOLTERODINE AND PROCESS FOR PREPARING THE SAME
#1505MULTIPLE UNIT DOSAGE FORM OF NIACIN
#1506Pharmaceutical formulation
#1507Stable digestive enzyme compositions
#1508SOFT CAPSULE
#1509Carbidopa/Levodopa gastroretentive drug delivery
#1510COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#1511Compositions and methods for inhibiting gastric acid secretion
#1512PHARMACEUTICAL FORMULATION
#1513Electronic pill comprising a medicine reservoir
#1514MULTIMICROPARTICULATE PHARMACEUTICAL FORMS FOR ORAL ADMINISTRATION
#1515Gastric acid secretion inhibiting composition
#1516Tamper-resistant oral opioid agonist formulations
#1517Reduction of cross-linking gelatin in gelatin capsules
#1518BACLOFEN AND R-BACLOFEN GASTRORETENTIVE DRUG DELIVERY SYSTEMS
#1519Micronized tanaproget and compositions containing same
#1520Anti-misuse solid oral pharmaceutical form provided with a specific modified release profile
#1521Sealed capsule including an integrated puncturing mechanism
#1522Abuse resistant drugs, method of use and method of making
#1523Method and composition for treating alzheimer-type dementia
#1524Methods and compositions for the treatment of CNS-related conditions
#1525Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
#1526Frangible capsule-in-capsule chemical delivery systems and methods of fabrication
#1527High strength seamless alginate capsules
#1528Seamless alginate capsules
#1529PHARMACEUTICAL PREPARATION FOR TREATING CARDIOVASCULAR DISEASE
#1530Antidepressant Oral Pharmaceutical Compositions
#1531COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#1532FORMULATIONS OF FLIBANSERIN
#1533COMPOSITE PREPARATION
#1534Pure sustained dichroa ferbrifuga alkone formulation
#1535COMBINATION DOSAGE FORM OF LOW-DOSE MODAFINIL AND LOW-DOSE SILDENAFIL
#1536Combination of Oral Medicaments Bonded by a Wrapping
#1537DELAYED RELEASE COMPOSITIONS OF DULOXETINE
#1538Stable solid preparations
#1539NANOMOLDING MICRON AND NANO SCALE FEATURES
#1540Abuse resistant oral opioid formulations
#1541Methods and compositions for the treatment of CNS-related conditions
#1542Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation
#1543PHARMACEUTICAL FORMULATIONS
#1544SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION CONTAINING AN ANTIMUSCARINIC AGENT AND A WETTING AGENT AS WELL AS A PROCESS FOR THE PREPARATION THEREOF
#1545NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
#1546Method and apparatus for in situ drug delivery during distraction osteogenesis
#1547MILNACIPRAN FORMULATIONS
#1548Capsule Formulation
#1549Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
#1550Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells
#1551Method for treating celiac disease
#1552Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
#1553CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOF
#1554Stable digestive enzyme compositions
#1555Pharmaceutical formulation containing irritant
#1556Oral pharmaceutical dosage forms
#1557Abuse-deterrent drug formulations
#1558Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
#1559Functionally Coated Breakable Tablets
#1560Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
#1561Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same
#1562Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration
#1563PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDE
#1564PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
#1565PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
#1566Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride
#1567PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
#1568Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts
#1569Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products
#1570SUSTAINED-RELEASE FORMULATIONS
#1571Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions
#1572CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#1573Low dose topiramate/phentermine composition and methods of use thereof
#1574Device and method for reducing calorie intake
#1575Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level
#1576Controlled release pharmaceutical formulations of nitazoxanide
#1577Controlled release budesonide minitablets
#1578Controlled release budesonide minitablets
#1579Pharmaceutical compositions of duloxetine
#1580GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS
#1581Multi-compartmented container
#1582Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
#1583Novel Pharmaceutical Modified Release Dosage Form Cyclooxygenase Enzyme Inhibitor
#1584Pharmaceutical compositions resistant to abuse
#1585Pharmaceutical treatment process using chitosan or derivative thereof
#1586DEVICE AND METHOD FOR REDUCING CALORIE INTAKE
#1587ORLISTAT PHARMACEUTICAL FORMULATIONS
#1588OROS PUSH-STICK FOR CONTROLLED DELIVERY OF ACTIVE AGENTS
#1589In vivo device, system and usage thereof
#1590Abscisic acid against cancer
#1591Pharmaceutical formulation containing gelling agent
#1592EXTENDED-RELEASE PHARMACEUTICAL FORMULATIONS
#1593Extended-Release Pharmaceutical Formulations
#1594Stable Combinations of Amlodipine Besylate and Benazepril Hydrochloride
#1595CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#1596PHARMACEUTICAL COMPOSITION
#1597Gastric acid secretion inhibiting composition
#1598Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
#1599IMPLANTABLE ANALGESIC
#1600Bile acid recycling inhibitors for treatment of obesity and diabetes
#1601Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
#1602Device and method for examining a body lumen
#1603Multi-component pharmaceutical dosage form
#1604Process and machine for automated manufacture of gastro-retentive devices
#1605COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#1606COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#1607Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
#1608EXTENDED RELEASE FORMULATIONS OF A PROTON PUMP INHIBITOR
#1609Abuse-resistant oral dosage forms and method of use thereof
#1610DIPYRIDAMOLE AND ACETYLSALICYLIC ACID FORMULATIONS AND PROCESS FOR PREPARING SAME
#1611TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS
#1612Pharmaceutical composition comprising tramadol and ketoprofen in association
#1613Pharmaceutical Formulation Comprising Donepezil
#1614PNEUMONIA TREATMENT
#1615ORGANIC COMPOUNDS
#1616Methods and Compositions for the Treatment of CNS-Related Conditions
#1617Pharmaceutical composition for piperidinoalkanol compounds
#1618Stable digestive enzyme compositions
#1619Enhanced-diffusion capsule
#1620INJECTION-MOLDED WATER SOLUBLE CONTAINER
#1621COMPOSITION AND COMBINATIONS OF CARBOXYLIC ACID LOSARTAN IN DOSAGE FORMS
#1622Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
#1623Gastroretentive drug delivery system comprising an extruded hydratable polymer
#1624SOLVENT SYSTEM OF HARDLY SOLUBLE DRUG WITH IMPROVED DISSOLUTION RATE
#1625Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D
#1626Combination preparations of o-acetylsalicylic acid salts
#1627CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#1628Gastro-Retentive System for the Delivery of Macromolecules
#1629Method and apparatus for forming delivery devices for oral intake of an agent
#1630Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor
#1631Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor
#1632FORMULATIONS FOR POORLY PERMEABLE ACTIVE PHARMACEUTICAL INGREDIENTS
#1633DEXLANSOPRAZOLE COMPOSITIONS
#1634STABLE COMBINATIONS OF AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
#1635Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
#1636Abuse-resistant oral dosage forms and method of use thereof
#1637SUSTAINED DELIVERY OF ANTIBIOTICS
#1638Pharmaceutical composition having reduced abuse potential
#1639ORAL DOSAGE COMBINATION PHARMACEUTICAL PACKAGING
#1640Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic-analgesic drug and proton pump inhibitor
#1641Triple drug combinations for psychiatric patients
#1642Extended-release capsules comprising venlafaxine hydrochloride
#1643CONTROLLED RELEASE FORMULATION COMPRISING ANTI-EPILEPTIC DRUGS
#1644PHARMACEUTICAL COMPOSITION COMPRISING MICROCAPSULES OF STATINS SUSPENDED IN ALKYL ESTERS OF POLYUNSATURATED FATTY ACIDS (PUFA)
#1645PHARMACEUTICAL COMPOSITIONS
#1646Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products
#1647Utilization of dialkylfumarates
#1648Utilization of dialkylfumarates
#1649Pharmaceutical compositions
#1650Controlled Release Formulations Comprising Uncoated Discrete Unit(s) and an Extended Release Matrix
#1651Pharmaceutical compositions
#1652Pharmaceutical composition
#1653Sustained release formulations containing acetaminophen and tramadol
#1654Gelatin Capsule With Extra Cap for Combined Therapies
#1655Particles in a capsule
#1656DISPENSING ENCAPSULATED LIQUIDS INTO BODY CAVITIES
#1657Multipart capsule for staged release of one or more pharmaceutical compositions
#1658Natural immunostimulant compositions, methods for obtaining the same and pharmaceutical formulations thereof
#1659MEDICAL CAPSULE
#1660Compositions and Methods for Enhancement of Sexual Function
#1661STABLE DIGESTIVE ENZYME COMPOSITIONS
#1662Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms
#1663Paneled capsule shells for release of pharmaceutical compositions
#1664Novel nifedipine compositions
#1665Compositions comprising lipophilic active compounds and method for their preparation
#1666Satiety
#1667NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS
#1668METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS
#1669ORAL DOSAGE COMBINATION PHARMACEUTICAL PACKAGING
#1670Pharmaceutical composition containing gelling agent
#1671Enterically coated cystamine, cysteamine and derivatives thereof
#1672Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
#1673Crystalline pyrimidine nucleoside derivative suspensions in capsules
#1674ORAL RAPID RELEASE PHARMACEUTICAL FORMULATION FOR PYRIDYLMETHYLSULFINYL-BENZIMIDAZOLES
#1675Novel nifedipine compositions
#1676Pulsatile gastric retentive dosage forms
#1677Pharmaceutical compositions of rifaximin
#1678CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF
#1679Novel Substituted Benzimidazole Dosage Forms and Method of Using Same
#1680Modified release dosage forms of skeletal muscle relaxants
#1681Modified release dosage forms of skeletal muscle relaxants
#1682METHOD OF REDUCING SOMNOLENCE IN PATIENTS TREATED WITH TIZANIDINE
#1683Once daily formulations of tetracyclines
#1684Injection Molded Water-Soluble Container
#1685Dosage form with impeded abuse
#1686CONTROLLED RELEASE ORAL FORMULATIONS OF ION CHANNEL MODULATING COMPOUNDS AND RELATED METHODS FOR PREVENTING ARRHYTHMIA
#1687Modified release solid or semi-solid dosage forms
#1688Tamper-resistant oral opioid agonist formulations
#1689Tamper-resistant oral opioid agonist formulations
#1690CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM
#1691Inhalator Capsules
#1692Tamper-resistant oral opioid agonist formulations
#1693Tamper-resistant oral opioid agonist formulations
#1694Ibuprofen-Hydrocodone-Antihistamine Composition
#1695Dosage forms for movement disorder treatment
#1696Stable digestive enzyme compositions
#1697Injection Molded Water-Soluble Container
#1698Bariatric magnetic apparatus and method of manufacturing thereof
#1699Pharmaceutical compositions containing terbinafin and use thereof
#1700Methods of producing stable pancreatic enzyme compositions
#1701Stable pancreatic enzyme compositions
#1702Stable Solid Dosage Forms of Amlodipine and Benazepril
#1703Controlled Release Compositions Comprising an Antipsychotic Agent
#1704Compositions and methods for inhibiting gastric acid secretion
#1705MULTILAYERED POLYELECTROLYTE-BASED CAPSULES FOR CELL ENCAPSULATION AND DELIVERY OF THERAPEUTIC COMPOSITIONS
#1706Melatonin-based composition for improved sleep
#1707Melatonin-based composition for improved sleep
#1708COMBINED PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE COMPRISING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND HMG-COA REDUCTASE INHIBITORS
#1709PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
#1710Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
#1711Fumaric Acid Derivatives as NF-kappaB Inhibitor
#1712Combination enzyme products
#1713Process and machine for automated manufacture of gastro-retentive devices
#1714Once daily dosage forms of trospium
#1715Method of treating bladder dysfunction with once-a-day trospium salt formulation
#1716Trospium chloride treatment method
#1717Once daily dosage forms of trospium
#1718Pharmaceutical compositions for sleep disorders
#1719Pharmaceutical compositions of amlodipine and benazepril
#1720Extended Release Venlafaxine Compositions
#1721ORAL DRUG CAPSULE COMPONENT INCORPORATING A COMMUNICATION DEVICE
#1722Abuse-resistant oral dosage forms and method of use thereof
#1723Cell delivery matrices
#1724Methods and compositions for deterring abuse of orally administered pharmaceutical products
#1725PHARMACEUTICAL COMPOSITION OF ZOLPIDEM
#1726Modified release dosage forms of skeletal muscle relaxants
#1727Modified release dosage forms of skeletal muscle relaxants
#1728Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
#1729Microcapsules for removing and absorbing a chemical from a mixture
#1730Quick Dissolve Medicament and Method of Manufacturing
#1731Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
#1732Device and method for reducing calorie intake
#1733Paired/matched medication
#1734Topiramate compositions and methods of enhancing its bioavailability
#1735Dosage forms for tamper prone therapeutic agents
#1736Injection-Molded Water Soluble Container
#1737Active Drug Delivery in the Gastrointestinal Tract
#1738Sinker capsules
#1739Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors
#1740METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL
#1741Gastric acid secretion inhibiting composition
#1742SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#1743Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition
#1744Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule Coats
#1745Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders
#1746Oral dosage forms
#1747COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#1748Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
#1749Modified Release Tablet Formulations for Proton Pump Inhibitors
#1750Controlled Release Compositions Comprising Levetiracetam
#1751Novel Extended Release Composition of Venlafaxine Hydrochloride Containing Polyvinyl Acetate
#1752Sustained release formulations of opioid and nonopioid analgesics
#1753Multimicroparticulate pharmaceutical forms for oral administration
#1754Pharmaceutical formulations
#1755Controlled dose drug delivery system
#1756PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALKANOL COMPOUNDS
#1757Utilization of dialkylfumarates
#1758Utilization of dialkylfumarates
#1759Capsule for Releasing Agents Contained Therein at Defined Points In a Body
#1760STATIN STABILIZING DOSAGE FORMULATIONS
#1761METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL
#1762METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL
#1763Methods and compositions for deterring abuse of orally administered pharmaceutical products
#1764Dosage Form Having Polymorphic Stability
#1765ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION
#1766Coating capsules with active pharmaceutical ingredients
#1767APPETITE SUPPRESSION DEVICE
#1768DOSAGE FORMS
#1769Pharmaceutical Formulations
#1770Formulations for a tight junction effector
#1771Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
#1772Dipyridamole extended-release formulations and process for preparing same
#1773Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
#1774Pharmaceutical compositions comprising of proton pump inhibitor and prokinetic agent
#1775Single unit pharmaceutical composition comprising a mixture of fenofibrate and a modified release form of a homocysteine reducing agent
#1776Solid ganaxolone formulations and methods for the making and use thereof
#1777Dosage forms for movement disorder treatment
#1778PHYSICALLY/MOLECULARLY DISTRIBUTED AND/OR CHEMICALLY BOUND MEDICAMENTS IN CAPSULE SHELLS
#1779Liquid ganaxolone formulations and methods for the making and use thereof
#1780SEQUENTIAL RELEASE PHARMACEUTICAL FORMULATIONS
#1781MODIFIED AND PULSATILE RELEASE PHARMACEUTICAL FORMULATIONS OF ESCITALOPRAM
#1782Pharmaceutical formulations
#1783STABLE PHARMACEUTICAL COMPOSITIONS
#1784Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances
#1785Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride
#1786GALANTAMINE COMPOSITIONS
#1787Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin
#1788Multi-component pharmaceutical dosage form
#1789Oral dosage combination pharmaceutical packaging
#1790Modified Release Formulations of Antihypertensive Drugs
#1791Modified release formulations of antihypertensive drugs
#1792Microfabricated nanopore device for sustained release of therapeutic agent
#1793MULTIPLE UNIT MODIFIED RELEASE COMPOSITIONS OF CARBAMAZEPINE AND PROCESS FOR THEIR PREPARATION
#1794Stable combinations of amlodipine besylate and benazepril hydrochloride
#1795Preparing for individualized dosage forms of medicaments
#1796MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#1797Method for banding hard capsules using hydroxypropylmethyl cellulose (HPMC) as a base
#1798Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same
#1799Methods of screening for antagonists of APM1/GZIP
#1800Edible coded microsubstrate for pharmaceuticals